Recently, reduction in FNDC5 expression was significantly associated to enhanced SkM autophagy and atrophy under urotensin II (UII) induction in vivo in a mouse model of CKD and in vitro in C2C12 cells. This evidence concerns the gene FNDC5 and chronic kidney disease.